Overview

Januvia Re-examination Study (MK-0431-181)

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The objectives of this survey are: 1) To examine the safety/efficacy profile of Januvia in Korean participants, and 2) To identify factors that might have an influence on the safety and efficacy profile of Januvia in Korean participants. Post-marketing surveys are not considered applicable clinical trials and thus the results of this survey will not be posted at its conclusion. The results will be submitted to public health officials as required by applicable national and international laws.
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Insulin
Insulin, Globin Zinc
Sitagliptin Phosphate